跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
LAMISIL terbinafine 250mg (as hydrochloride) tablet
Approved
STANDARD
LAMISIL terbinafine 250mg (as hydrochloride) tablet
Novartis Pharmaceuticals Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
d3c58cd1a2be9ee1
Company
Novartis Pharmaceuticals Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
d3c58cd1a2be9ee1
Product Name
LAMISIL terbinafine 250mg (as hydrochloride) tablet
Artg Id
43523
Artg Name
LAMISIL terbinafine 250mg (as hydrochloride) tablet blister pack
Sponsor
Novartis Pharmaceuticals Australia Pty Ltd
Company Detail Path
/organization/novartis-pharmaceuticals-australia-pty-ltd
Artg Date
1993-09-24
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/f420575f1566e85afddd69af5bed9ac6.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/d6def53408c630a73659973a5dc802b5.pdf
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
d3c58cd1a2be9ee1
Type
Standard
Back to TGA Approvals
LAMISIL terbinafine 250mg (as hydrochloride) tablet - TGA Drug Approval Details
